ONESOURCE · Onesource Specialty Pharma Limited · Financials
Volume · Nov 13
55.01K
Avg daily vol (3M)
47.86K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
14.22B
-1.6%
FY2026
Net Income
-738.03M
-310.7%
FY2026
Operating Cash Flow
85.23M
+139.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 15.43B | 14.22B | 14.45B |
| INR | 2.83B | 2.79B | 2.74B |
| INR | 1.26B | 1.22B | 1.66B |
| INR | -672.68M | -919.61M | -670.66M |
| INR | -186.48M | -181.58M | -497.85M |
| INR | -736.17M | -738.03M | -179.71M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.